These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 1828840)
41. The response of students to malaria and malaria therapy in a university in southwest Nigeria. Babalola OO; Lamikanra A Res Social Adm Pharm; 2007 Sep; 3(3):351-62. PubMed ID: 17945163 [TBL] [Abstract][Full Text] [Related]
42. Evaluation of the clinical efficacy and safety of halofantrine in falciparum malaria in Ibadan, Nigeria. Salako LA; Sowunmi A; Walker O Trans R Soc Trop Med Hyg; 1990; 84(5):644-7. PubMed ID: 2278061 [TBL] [Abstract][Full Text] [Related]
43. Knowledge and management of malaria in Dar es Salaam, Tanzania. Massele AY; Sayi J; Nsimba SE; Ofori-Adjei D; Laing RO East Afr Med J; 1993 Oct; 70(10):639-42. PubMed ID: 8187661 [TBL] [Abstract][Full Text] [Related]
45. Clinical trials with halofantrine in acute uncomplicated falciparum malaria in Thailand. Bunnag D; Viravan C; Karbwang J; Looareesuwan S; Chittamas S; Harinasuta T; Serville P; Horton J Southeast Asian J Trop Med Public Health; 1993 Mar; 24(1):43-8. PubMed ID: 8362305 [TBL] [Abstract][Full Text] [Related]
46. Pharmacokinetics of halofantrine in Thai patients with acute uncomplicated falciparum malaria. Karbwang J; Milton KA; Na Bangchang K; Ward SA; Edwards G; Bunnag D Br J Clin Pharmacol; 1991 Apr; 31(4):484-7. PubMed ID: 2049260 [TBL] [Abstract][Full Text] [Related]
47. Intravascular haemolysis following treatment of malaria with halofantrine: case report. Fehintola FA; Falade CO; Sowunmi A Niger J Clin Pract; 2006 Dec; 9(2):174-5. PubMed ID: 17319353 [No Abstract] [Full Text] [Related]
48. A severe adverse reaction to mefloquine and chloroquine prophylaxis. Lysack JT; Lysack CL; Kvern BL Aust Fam Physician; 1998 Dec; 27(12):1119-20. PubMed ID: 9919736 [TBL] [Abstract][Full Text] [Related]
49. Efficacy of halofantrine in the treatment of uncomplicated falciparum malaria. Mbori-Ngacha DA; Onyango FE; Chunge C; Luta M; Oloo AJ; Muga RO East Afr Med J; 1995 Dec; 72(12):796-9. PubMed ID: 8689980 [TBL] [Abstract][Full Text] [Related]
51. Chloroquine-associated pruritus in a European. Spencer HC; Poulter NR; Lury JD; Poulter CJ Br Med J (Clin Res Ed); 1982 Dec; 285(6356):1703-4. PubMed ID: 6216940 [No Abstract] [Full Text] [Related]
52. Clinical pharmacokinetics of halofantrine. Karbwang J; Na Bangchang K Clin Pharmacokinet; 1994 Aug; 27(2):104-19. PubMed ID: 7955774 [TBL] [Abstract][Full Text] [Related]
53. Halofantrine. A review of its antimalarial activity, pharmacokinetic properties and therapeutic potential. Bryson HM; Goa KL Drugs; 1992 Feb; 43(2):236-58. PubMed ID: 1372221 [TBL] [Abstract][Full Text] [Related]
54. Itching for insight. Bandell M; Patapoutian A Cell; 2009 Dec; 139(7):1224-6. PubMed ID: 20064368 [TBL] [Abstract][Full Text] [Related]
55. Pruritus and antimalarial drugs in Africans. Sowunmi A; Walker O; Salako LA Lancet; 1989 Jul; 2(8656):213. PubMed ID: 2568535 [No Abstract] [Full Text] [Related]
56. Chloroquine-induced pruritus among patients with malaria. Osifo NG Arch Dermatol; 1984 Jan; 120(1):80-2. PubMed ID: 6691718 [TBL] [Abstract][Full Text] [Related]
57. Pustular eruption in a malaria patient treated with chloroquine. Wilairatana P; Looareesuwan S; Riganti M; Teja-Isavadharm P; Keeratithakul D; Eickmeyer S; Walsh DS Int J Dermatol; 1998 Sep; 37(9):713-4. PubMed ID: 9762829 [No Abstract] [Full Text] [Related]
58. The disposition of chloroquine and its main metabolite desethylchloroquine in volunteers with and without chloroquine-induced pruritus: evidence for decreased chloroquine metabolism in volunteers with pruritus. Ademowo OG; Sodeinde O; Walker O Clin Pharmacol Ther; 2000 Mar; 67(3):237-41. PubMed ID: 10741626 [TBL] [Abstract][Full Text] [Related]
59. The effects of prednisolone and niacin on chloroquine-induced pruritus in malaria. Ajayi AA; Akinleye AO; Udoh SJ; Ajayi OO; Oyelese O; Ijaware CO Eur J Clin Pharmacol; 1991; 41(4):383-5. PubMed ID: 1804657 [TBL] [Abstract][Full Text] [Related]
60. Prolongation of the QT interval observed in a Japanese patient with vivax malaria following treatment with halofantrine. Kano S; Hayashi A; Kanda T; Suzuki M Kansenshogaku Zasshi; 1995 Dec; 69(12):1408-12. PubMed ID: 8586895 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]